Tauriga Sciences Inc. Retains FAMR to Commence Bidding Process on Several Identified U.S. Government Contracts

Rhea-AI Summary

Tauriga Sciences (OTCQB: TAUG) has retained Federal Award Management Registration (FAMR) to bid on potential U.S. Government Contracts from the Department of Defense (DOD). This follows the company being approved as a U.S. Government Vendor. Tauriga is a diversified life sciences company known for its Tauri-Gum™ product line, which includes CBD-infused chewing gums and ongoing biotechnology initiatives like a pharmaceutical-grade gum for nausea and a COVID-19 test development project. The company continues to grow its retail and e-commerce operations.

Positive

• Retained FAMR to pursue significant U.S. Government Contracts.
• Approved as a U.S. Government Vendor, enhancing credibility.
• Diversified product offerings in CBD and CBG markets.
• Ongoing biotechnology initiatives may lead to substantial future revenue.

Negative

• None.

NEW YORK, NY, Oct. 09, 2020 (GLOBE NEWSWIRE) -- via NewMediaWire -- Tauriga Sciences, Inc. (OTCQB: TAUG) (“Tauriga” or the “Company”), a revenue generating, diversified life sciences company, with a proprietary line of functional “supplement” chewing gums (Flavors: Pomegranate, Blood Orange, Peach-Lemon, Pear Bellini, Mint, Black Currant) as well as two ongoing Biotechnology initiatives, today announced that it has retained Federal Award Management Registration (“FAMR”) to commence the bidding process on several identified potential U.S. Government Contracts (“Contracts”).  These potential Contracts are presented by the Department of Defense (“DOD”).  FAMR is an independent consulting firm that specializes in: Registrations, Certifications, and Federal Contracting.

On October 06, 2020, the Company announced that it was officially approved to operate as a U.S. Government Vendor.  The Company’s Commercial & Government Entity (“CAGE”) Code # is: 8QXV4 with an expiration date of October 01, 2021.

ABOUT TAURIGA SCIENCES INC.

Tauriga Sciences, Inc. (TAUG) is a revenue generating, diversified life sciences company, engaged in several major business activities and initiatives.  The company manufactures and distributes several proprietary retail products and product lines, mainly focused on the Cannabidiol (“CBD”) and Cannabigerol (“CBG”) Edibles market segment.  The main product line, branded as Tauri-Gum™, consists of a proprietary supplement chewing gum that is Kosher certified, Halal certified, and Vegan Formulated (CBD Infused Tauri-Gum™ Flavors: Mint, Blood Orange, Pomegranate), (CBG Infused Tauri-Gum™ Flavors: Peach-Lemon, Black Currant) & (Vitamin C + Zinc “Immune Booster” Tauri-Gum™ Flavor: Pear Bellini).  The Company’s commercialization strategy consists of a broad array of retail customers, distributors, and a fast-growing E-Commerce business segment (E-Commerce website: www.taurigum.com). Please visit our corporate website, for additional information, as well as inquiries, at http://www.tauriga.com

Complementary to the Company’s retail business, are its two ongoing biotechnology initiatives.  The first one relates to the development of a Pharmaceutical grade version of Tauri-Gum™, for nausea regulation (specifically designed to help patients that are subjected to ongoing chemotherapy treatment). On March 18, 2020, the Company announced that it filed a provisional U.S. patent application covering its pharmaceutical grade version of Tauri-Gum™.  The Patent, filed with the U.S.P.T.O. is Titled “MEDICATED CBD COMPOSITIONS, METHODS OF MANUFACTURING, AND METHODS OF TREATMENT”. The second one relates to a collaboration agreement with Aegea Biotechnologies Inc. for the co-development of a rapid, multiplexed, Novel Coronavirus (COVID-19) test with superior sensitivity and selectivity.   

On October 7, 2020 the Company disclosed a Strategic Alliance with Think BIG, LLC, Social Impact Startup Founded by CJ Wallace, Son of Christopher “The Notorious B.I.G.” Wallace.

The Company is headquartered in New York City and operates a regional office in Barcelona, Spain.  In addition, the Company operates a full time E-Commerce fulfillment center located in LaGrangeville, New York.

DISCLAIMER -- Forward-Looking Statements

This press release contains certain “forward-looking statements” as defined by the Private Securities Litigation Reform Act of 1995 which represent management’s beliefs and assumptions concerning future events. These forward-looking statements are often indicated by using words such as “may,” “will,” “expects,” “anticipates,” believes, “hopes,” “believes,” or plans, and may include statements regarding corporate objectives as well as the attainment of certain corporate goals and milestones. Forward-looking statements are based on present circumstances and on management’s present beliefs with respect to events that have not occurred, that may not occur, or that may occur with different consequences or timing than those now assumed or anticipated. Actual results may differ materially from those expressed in  forward looking statements due to known and unknown risks and uncertainties, such as are not guarantees of general economic and business conditions, the ability to successfully develop and market products, consumer and business consumption habits, the ability to consummate successful acquisition and licensing transactions, fluctuations in exchange rates, and other factors over which Tauriga has little or no control. Many of these risks and uncertainties are discussed in greater detail in the “Risk Factors” section of Tauriga’s Form 10-K and other filings made from time to time with the Securities and Exchange Commission. Such forward-looking statements are made only as of the date of this release, and Tauriga assumes no obligation to update forward-looking statements to reflect subsequent events or circumstances. You should not place undue reliance on these forward-looking statements.

CONTACT INFORMATION

Tauriga Sciences, Inc.
555 Madison Avenue, 5th Floor
New York, NY  10022
Chief Executive Officer
Mr. Seth M. Shaw
Email:  sshaw@tauriga.com 
cell # (917) 796 9926
Instagram: @taurigum
Twitter: @SethMShaw
Corp.Website:   www.tauriga.com
E-Commerce Website:  www.taurigum.com

FAQ

What contracts is Tauriga Sciences pursuing?

Tauriga Sciences is pursuing potential U.S. Government Contracts facilitated by the Department of Defense.

What is the significance of Tauriga being approved as a U.S. Government Vendor?

Being approved as a U.S. Government Vendor enhances Tauriga's credibility and opens opportunities for government contracts.

What products does Tauriga Sciences offer?

Tauriga offers a line of functional chewing gums including CBD and CBG infused flavors, as well as a vitamin-enhanced gum.

What biotechnology initiatives is Tauriga involved in?

Tauriga is developing a pharmaceutical-grade chewing gum for nausea regulation and collaborating on a COVID-19 test.

What is the stock symbol for Tauriga Sciences?

The stock symbol for Tauriga Sciences is TAUG.